US Food and Drug Administration

The Perron Institute is kicking commercial goals, courtesy of big sales royalties and a planned ASX listing.

A WA-developed imaging device that can reduce the number of repeat surgeries for breast cancer patients has received a major accreditation from the US Food and Drug Administration.